ARTICLE
7 January 2014

OIG Calls For Greater Scrutiny Of Clinicians with High Cumulative Medicare Payments

The OIG has issued a report focusing on individual clinicians who generated high cumulative Medicare Part B payments (defined for purposes of this report as more than $3 million in Part B services) in 2009.
United States Food, Drugs, Healthcare, Life Sciences

The OIG has issued a report focusing on individual clinicians who generated high cumulative Medicare Part B payments (defined for purposes of this report as more than $3 million in Part B services) in 2009. Out of 303 such clinicians identified by the OIG, 34% had been identified for improper payment reviews, and as of December 31, 2011, they were tied to $34 million in overpayments, three of the clinicians had their medical licenses suspended and two were indicted. Since existing procedures may not always identify clinicians responsible for high cumulative payments in a timely manner, the OIG recommends that CMS: (1) establish a cumulative payment threshold above which a clinician's claims would be selected for review, and (2) implement a procedure for timely identification and review of clinicians' claims that exceed the cumulative payment threshold. While CMS noted that "[h]igh cumulative payments are not necessarily indicative of improper payments or fraud," the agency partially concurred with the OIG recommendations and stated that it would work with its contractors to develop an appropriate, cumulative payment threshold.

This article is presented for informational purposes only and is not intended to constitute legal advice.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More